Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Iroxanadine hydrochloride is a MAPK p38 inhibitor potentially for the treatment of atherosclerosis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 2,270.00 | |
50 mg | 10-14 weeks | $ 2,980.00 | |
100 mg | 10-14 weeks | $ 4,000.00 |
Description | Iroxanadine hydrochloride is a MAPK p38 inhibitor potentially for the treatment of atherosclerosis. |
Molecular Weight | 296.8 |
Formula | C14H21ClN4O |
CAS No. | 276690-59-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Iroxanadine hydrochloride 276690-59-6 Iroxanadine Hydrochloride Iroxanadine HCl inhibitor inhibit